The APAP dose employed in our study evidenced the toxic action of the drug to the liver, generating hepatocellular death and increased ALT and AST levels associated with an inflammatory process, thus reproducing important parameters of DILI and acute liver failure in humans [43]. The gene discussed is GPT; the disease is acute liver failure.